Home
fajas en target
Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial

Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial

4.6 (352) · $ 18.00 · In stock

A randomized trial comparing the platinum-chromium everolimus-eluting stent to the cobalt-chromium everolimus-eluting stent in 2980 all-comers patients undergoing PCI, finding the platinum-chromium stent noninferior for target vessel failure at 1 year.

Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial

PDF) A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease

The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre

Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation